Why Nigerian Men Are Dying Daily of Prostate Cancer
By Isaac Eranga
Award-winning Journalist | Benin City, Nigeria
“He thought it was just the normal weakness that comes with age. By the time he couldn’t pass urine without excruciating pain, the cancer had already eaten into his bones.”
— Osaigbovo Igbinoba, reflecting on the loss of his 62-year old father in Benin City.
Across the cities, towns, and rural communities of Nigeria, a quiet crisis is claiming the lives of thousands of fathers, husbands, and brothers every year. Prostate cancer has quietly elevated itself to the leading cause of cancer-related mortality among Nigerian men.
Data from GLOBOCAN indicates that Nigeria records over 18,000 new cases of prostate cancer annually, with over 11,000 resulting in death. Unlike in Western nations where early detection transforms prostate cancer into a highly manageable or curable condition, over 68% to 80% of Nigerian men are diagnosed at Stage III or Stage IV when the disease has already metastasized and become largely incurable.
Why are Nigerian men dying in such alarming numbers from a disease that can be treated when caught early? An investigative look into the country’s healthcare landscape, socio-cultural realities, and biological predispositions reveals a deadly convergence of factors.
1. The Genetic Matrix: African Ancestry and High Virulence
Medical research increasingly shows that prostate cancer behaves more aggressively in men of West African lineage.
Early Onset: While men of European descent are generally advised to begin screening at age 50, genetic studies indicate that men of African ancestry are at high risk starting as early as age 40.
Aggressive Phenotypes: Research from the Men of African Descent and Carcinoma of the Prostate Consortium (MADCaP) highlights specific inherited genetic polymorphisms (such as variants in the BRCA1, BRCA2, and HOXB13 genes) that make tumors in Black men grow faster and spread more aggressively.
Despite this heightened biological susceptibility, systemic routine screening remains virtually non-existent across Nigeria’s public health apparatus.
2. Late Presentation: The Culture of Silence, Fear, and Myths
In traditional Nigerian settings, discussing reproductive or urological health carries deep socio-cultural stigmas. Lower urinary tract symptoms—such as weak urine flow, frequent nighttime urination, or difficulty emptying the bladder are frequently dismissed as routine signs of aging.
The Fatal Progression Cycle
Initial Onset: A man begins noticing subtle urinary changes or mild discomfort.
Denial and Alternative Remedies: Symptoms are kept hidden, followed by months of self medication using untested herbal concoctions or seeking help at faith homes.
Severe Complications: The tumor breaches the prostate capsule, invading surrounding tissue and spreading to the spine or hips, causing unbearable bone pain.
Late Hospital Presentation: The patient finally visits a tertiary hospital, where scans reveal Stage III or IV advanced cancer.
Furthermore, widespread myths surrounding diagnostic procedures discourage men from seeking medical evaluation:
Fear of the Digital Rectal Exam (DRE): Many men avoid clinical visits due to misconceptions about DREs, viewing the physical examination as invasive or culturally taboo.
Fear of Impotence: The belief that prostate surgery or treatment automatically results in permanent erectile dysfunction leads many to delay hospital consultations until pain becomes unbearable.
Recourse to Unproven Remedies: A vast number of patients spend crucial months or years relying on unverified alternative treatments, presenting to tertiary medical centers only when organ failure sets in.
3. Financial Catastrophe and Healthcare Deficits
Even when a Nigerian man is willing to seek treatment, the economic reality of the country’s healthcare system poses an immense barrier. With limited national health insurance coverage for oncology, the financial burden falls almost entirely on the patient and their family.
Breakdown of Treatment Costs and Accessibility
PSA Screening Test: Costs between ₦15,000 and ₦35,000. While moderately available, it must be paid entirely out-of-pocket, putting it out of reach for lower-income men.
Prostate Biopsy & Staging: Costs between ₦150,000 and ₦350,000. These diagnostic services are largely restricted to major urban tertiary health centers.
Radical Surgery / Radiotherapy: Costs from ₦2,500,000 to over ₦6,000,000. These procedures are prohibitively expensive for most families, compounding a severe nationwide shortage of functioning radiotherapy machines.
Hormonal Therapy (Palliative Care): Costs between ₦100,000 and ₦300,000 monthly. This recurring expense serves as the primary treatment line for late-stage patients to manage pain and slow tumor growth.
Inadequate Infrastructure
Across Nigeria, tertiary hospitals capable of delivering advanced radiotherapy or laparoscopic prostatectomies are severely limited. Patients in rural areas often travel hundreds of kilometers to centers in Benin City, Ibadan, Lagos, or Abuja, facing long waiting lists that allow the cancer time to advance further.
The Path Forward: What Needs to Change?
The daily mortality toll from prostate cancer in Nigeria is not an inevitability—it is a public health challenge that requires targeted intervention. Experts and oncologists advocate for immediate action across three main pillars:
National Screening Policy: Government-backed routine screening initiatives targeting men aged 40 and above using affordable Prostate-Specific Antigen (PSA) blood tests.
Subsidized Cancer Care: Expanding national insurance schemes to cover diagnostics, surgery, radiotherapy, and hormone treatments to relieve the catastrophic financial burden on families.
Grassroots Awareness Campaigns: Aggressive public education to demystify prostate health, debunk screening myths, and encourage early hospital presentation.
“Until we treat prostate health with the same urgency as infectious diseases, we will continue to lose thousands of productive men prematurely to a disease that is largely treatable if caught early.”
